Single Dose Safety, Tolerance and Pharmacokinetic Study in Healthy Volunteers Undergoing Contrast-enhanced Abdominal Computed Tomography (CT)

Inclusion Criteria: * Healthy males and females between 18 and 60 years of age. * For women who are either surgically sterile or are postmenopausal, enrollment in the study without a pregnancy test at screening will be allowed. For women of childbearing potential, the results of a serum and urine HCG pregnancy test (with the result known on the day of and before IMP administration) must be negative. * Subjects are able and willing to comply with study procedures and sign an informed consent. Exclusion Criteria: * Known history of a reaction to any iodinated-based contrast agent or with multiple allergies (i.e. foods, pets, medications, etc). * Subjects receiving any medication for which the use of an iodinated contrast agent is contraindicated (i.e.. metformin). * Subjects with suspicion or diagnosis of hyperthyroidism. * Women that are breastfeeding at the screening and/or enrolment period. * Usage of any non-FDA-approved pharmaceutical or therapy within 30 days prior to screening or enrolment in another clinical study within 30 days prior to screening.